5-55231648-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021147.5(CCNO):c.780C>T(p.Ala260Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00445 in 1,588,502 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0046 ( 31 hom. )
Consequence
CCNO
NM_021147.5 synonymous
NM_021147.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.137
Publications
2 publications found
Genes affected
CCNO (HGNC:18576): (cyclin O) This gene encodes a member of the cyclin protein family, and the encoded protein is involved in regulation of the cell cycle. Disruption of this gene is associated with primary ciliary dyskinesia-19. Alternative splicing results in multiple transcript variants. This gene, which has a previous symbol of UNG2, was erroneously identified as a uracil DNA glycosylase in PubMed ID: 2001396. A later publication, PubMed ID: 8419333, identified this gene's product as a cyclin protein family member. The UNG2 symbol is also used as a specific protein isoform name for the UNG gene (GeneID 7374), so confusion exists in the scientific literature and in some databases for these two genes. [provided by RefSeq, Jul 2014]
CCNO Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 29Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, Ambry Genetics
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 5-55231648-G-A is Benign according to our data. Variant chr5-55231648-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241374.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.137 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00352 (536/152346) while in subpopulation SAS AF = 0.00621 (30/4832). AF 95% confidence interval is 0.0045. There are 5 homozygotes in GnomAd4. There are 258 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CCNO | NM_021147.5 | c.780C>T | p.Ala260Ala | synonymous_variant | Exon 3 of 3 | ENST00000282572.5 | NP_066970.3 | |
| CCNO | NR_125346.2 | n.1241C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | ||||
| CCNO | NR_125347.2 | n.870C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | ||||
| CCNO | NR_125348.1 | n.844C>T | non_coding_transcript_exon_variant | Exon 2 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CCNO | ENST00000282572.5 | c.780C>T | p.Ala260Ala | synonymous_variant | Exon 3 of 3 | 1 | NM_021147.5 | ENSP00000282572.4 | ||
| CCNO | ENST00000501463.2 | n.*760C>T | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | ENSP00000422485.1 | ||||
| CCNO | ENST00000501463.2 | n.*760C>T | 3_prime_UTR_variant | Exon 3 of 3 | 1 | ENSP00000422485.1 |
Frequencies
GnomAD3 genomes AF: 0.00353 AC: 538AN: 152228Hom.: 5 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
538
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00451 AC: 893AN: 198212 AF XY: 0.00484 show subpopulations
GnomAD2 exomes
AF:
AC:
893
AN:
198212
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00455 AC: 6540AN: 1436156Hom.: 31 Cov.: 31 AF XY: 0.00478 AC XY: 3404AN XY: 712596 show subpopulations
GnomAD4 exome
AF:
AC:
6540
AN:
1436156
Hom.:
Cov.:
31
AF XY:
AC XY:
3404
AN XY:
712596
show subpopulations
African (AFR)
AF:
AC:
53
AN:
32956
American (AMR)
AF:
AC:
244
AN:
40246
Ashkenazi Jewish (ASJ)
AF:
AC:
94
AN:
25634
East Asian (EAS)
AF:
AC:
0
AN:
38258
South Asian (SAS)
AF:
AC:
623
AN:
83802
European-Finnish (FIN)
AF:
AC:
72
AN:
50342
Middle Eastern (MID)
AF:
AC:
161
AN:
5706
European-Non Finnish (NFE)
AF:
AC:
4949
AN:
1099844
Other (OTH)
AF:
AC:
344
AN:
59368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
443
887
1330
1774
2217
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00352 AC: 536AN: 152346Hom.: 5 Cov.: 33 AF XY: 0.00346 AC XY: 258AN XY: 74518 show subpopulations
GnomAD4 genome
AF:
AC:
536
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
258
AN XY:
74518
show subpopulations
African (AFR)
AF:
AC:
42
AN:
41588
American (AMR)
AF:
AC:
52
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
12
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
30
AN:
4832
European-Finnish (FIN)
AF:
AC:
12
AN:
10624
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
336
AN:
68026
Other (OTH)
AF:
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Jan 20, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
CCNO: BP4, BP7, BS2
Primary ciliary dyskinesia Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.